LATISSE® is the first prescription product to treat inadequate lashes by prolonging the active eyelash growth phase. It’s clinically proven to deliver lashes that are fuller, longer, and darker at 16 weeks.
LATISSE® solution should always be placed on the provided applicator and applied carefully across the skin of the upper eyelid margin at the base of the eyelashes. LATISSE® solution should never be applied to the lower lid, in the eye, or as an eye drop.
LATISSE® may cause increased brown eye coloring (hyperpigmentation). This is rare but is likely permanent if it occurs. Brown eye coloring has occurred infrequently when LATISSE® solution was used.
1. Once nightly, make sure your face is clean and makeup and contact lenses are removed.
2. Remove a sterile applicator from the tray. Then, while holding the applicator horizontally, place one drop of LATISSE® on the area of the applicator closest to the tip but not on the tip.
3. Immediately brush the applicator carefully along the skin at the base of the upper eyelashes (where the eyelashes meet your skin), going from the inner part of your lash line to the outer part.
4.Use a tissue to blot any excess solution that goes beyond the eyelid.
5.Throw away the applicator. Each applicator should be used once.
6.Repeat the steps for the opposite eyelid with a new, sterile applicator.
Please reach Stephanie at 262-894-6717 if you cannot find an answer to your question.
Remove contact lenses prior to applying LATISSE® solution. Contact lenses may be reinserted 15 minutes after application. If you get LATISSE® in your eye, do not rinse your eye. It is not expected to cause harm.
If use of LATISSE® is discontinued, eyelashes will return to their previous appearance over the course of several weeks to months.
Lash growth is gradual while using LATISSE®. Some may start to notice longer lashes after about a month, and many should experience full results in 16 weeks. Individual results may vary.
Patients with hypersensitivity to bimatoprost or any other ingredient in this product, history of glaucoma or abnormal intraocular pressure (IOP), Pregnancy: while there are no adequate and well controlled studies for bimatoprost in pregnant woman, Latisse should not be administered during pregnancy since the potential benefit does not justify the potential risk to the fetus, similarly, nursing mothers should not take Latisse since many drugs are excreted in human milk.
Emerald Aesthetics
10920 West Forest Home Avenue, Hales Corners, Wisconsin 53130, United States

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.